Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 21, 2017; 23(7): 1171-1179
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1171
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1171
Figure 5 Thymoquinone efficiently inhibits LoVo cell migration.
LoVo cells were pretreated with increasing dosages (5, 10, and 20 μmol/L) of TQ for 24 h. A Boyden chamber migration assay was performed to assess cell migration ability. The responses to different treatments were analyzed via microscopy. PGE2: Prostaglandin E2; TQ: Thymoquinone.
- Citation: Hsu HH, Chen MC, Day CH, Lin YM, Li SY, Tu CC, Padma VV, Shih HN, Kuo WW, Huang CY. Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation. World J Gastroenterol 2017; 23(7): 1171-1179
- URL: https://www.wjgnet.com/1007-9327/full/v23/i7/1171.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i7.1171